D. Boral Capital Maintains Buy on Medicus Pharma, Maintains $27 Price Target

Benzinga · 07/09 12:55
D. Boral Capital analyst Jason Kolbert maintains Medicus Pharma (NASDAQ:MDCX) with a Buy and maintains $27 price target.